chr11-61951946-G-A
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 16P and 1B. PM1PM5PP3_StrongPP5_Very_StrongBS2_Supporting
The ENST00000378043.9(BEST1):c.140G>A(p.Arg47His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,461,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R47C) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000378043.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BEST1 | NM_004183.4 | c.140G>A | p.Arg47His | missense_variant | 2/11 | ENST00000378043.9 | NP_004174.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BEST1 | ENST00000378043.9 | c.140G>A | p.Arg47His | missense_variant | 2/11 | 1 | NM_004183.4 | ENSP00000367282 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251182Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135786
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461324Hom.: 0 Cov.: 34 AF XY: 0.0000110 AC XY: 8AN XY: 726954
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Vitelliform macular dystrophy 2 Pathogenic:3
Likely pathogenic, no assertion criteria provided | research | Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet | Apr 01, 2018 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2000 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | 3billion | Feb 23, 2023 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.002%). Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.70). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000002738). A different missense change at the same codon (p.Arg47Cys) has been reported to be associated with BEST1 related disorder (ClinVar ID: VCV000305117 / PMID: 21273940). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. - |
not provided Pathogenic:1Other:1
not provided, no classification provided | literature only | Retina International | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 47 of the BEST1 protein (p.Arg47His). This variant is present in population databases (rs28940278, gnomAD 0.01%). This missense change has been observed in individuals with autosomal recessive bestrophinopathy (PMID: 28687848, 29976937, 30498755). It has also been observed to segregate with disease in related individuals. This variant has been reported in individual(s) with autosomal dominant BEST1-related conditions (PMID: 10854112, 27078032, 30718709); however, the role of the variant in this condition is currently unclear. ClinVar contains an entry for this variant (Variation ID: 2738). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BEST1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change does not substantially affect BEST1 function (PMID: 24560797). This variant disrupts the p.Arg47 amino acid residue in BEST1. Other variant(s) that disrupt this residue have been observed in individuals with BEST1-related conditions (PMID: 21273940), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. - |
Vitelliform macular dystrophy 2;C2750789:Retinitis pigmentosa 50;C3888099:Autosomal dominant vitreoretinochoroidopathy;C3888198:Autosomal recessive bestrophinopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Juno Genomics, Hangzhou Juno Genomics, Inc | - | PM2_Supporting+PP3+PM3+PP1_Strong+PP4 - |
Retinal dystrophy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg | Jan 01, 2015 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at